1
|
Boone DR, Micci MA, Taglialatela IG, Hellmich JL, Weisz HA, Bi M, Prough DS, DeWitt DS, Hellmich HL. Pathway-focused PCR array profiling of enriched populations of laser capture microdissected hippocampal cells after traumatic brain injury. PLoS One 2015; 10:e0127287. [PMID: 26016641 PMCID: PMC4446038 DOI: 10.1371/journal.pone.0127287] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2014] [Accepted: 04/13/2015] [Indexed: 12/22/2022] Open
Abstract
Cognitive deficits in survivors of traumatic brain injury (TBI) are associated with irreversible neurodegeneration in brain regions such as the hippocampus. Comparative gene expression analysis of dying and surviving neurons could provide insight into potential therapeutic targets. We used two pathway-specific PCR arrays (RT2 Profiler Apoptosis and Neurotrophins & Receptors PCR arrays) to identify and validate TBI-induced gene expression in dying (Fluoro-Jade-positive) or surviving (Fluoro-Jade- negative) pyramidal neurons obtained by laser capture microdissection (LCM). In the Apoptosis PCR array, dying neurons showed significant increases in expression of genes associated with cell death, inflammation, and endoplasmic reticulum (ER) stress compared with adjacent, surviving neurons. Pro-survival genes with pleiotropic functions were also significantly increased in dying neurons compared to surviving neurons, suggesting that even irreversibly injured neurons are able to mount a protective response. In the Neurotrophins & Receptors PCR array, which consists of genes that are normally expected to be expressed in both groups of hippocampal neurons, only a few genes were expressed at significantly different levels between dying and surviving neurons. Immunohistochemical analysis of selected, differentially expressed proteins supported the gene expression data. This is the first demonstration of pathway-focused PCR array profiling of identified populations of dying and surviving neurons in the brain after TBI. Combining precise laser microdissection of identifiable cells with pathway-focused PCR array analysis is a practical, low-cost alternative to microarrays that provided insight into neuroprotective signals that could be therapeutically targeted to ameliorate TBI-induced neurodegeneration.
Collapse
Affiliation(s)
- Deborah R. Boone
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Maria-Adelaide Micci
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Isabella G. Taglialatela
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Judy L. Hellmich
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Harris A. Weisz
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Min Bi
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Donald S. Prough
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Douglas S. DeWitt
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
| | - Helen L. Hellmich
- Department of Anesthesiology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555–0830, United States of America
- * E-mail:
| |
Collapse
|
2
|
Nording HM, Seizer P, Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6:98. [PMID: 25798138 PMCID: PMC4351644 DOI: 10.3389/fimmu.2015.00098] [Citation(s) in RCA: 150] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2014] [Accepted: 02/19/2015] [Indexed: 12/12/2022] Open
Abstract
Platelets contribute to processes beyond thrombus formation and may play a so far underestimated role as an immune cell in various circumstances. This review outlines immune functions of platelets in host defense, but also how they may contribute to mechanisms of infectious diseases. A particular emphasis is placed on the interaction of platelets with other immune cells. Furthermore, this article outlines the features of atherosclerosis as an inflammatory vascular disease highlighting the role of platelet crosstalk with cellular and soluble factors involved in atheroprogression. Understanding, how platelets influence these processes of vascular remodeling will shed light on their role for tissue homeostasis beyond intravascular thrombosis. Finally, translational implications of platelet-mediated inflammation in atherosclerosis are discussed.
Collapse
Affiliation(s)
- Henry M. Nording
- University Clinic for Cardiology and Cardiovascular Medicine, Eberhard Karls-University Tübingen, Tübingen, Germany
- Section for Cardioimmunology, Eberhard Karls-University Tübingen, Tübingen, Germany
| | - Peter Seizer
- University Clinic for Cardiology and Cardiovascular Medicine, Eberhard Karls-University Tübingen, Tübingen, Germany
| | - Harald F. Langer
- University Clinic for Cardiology and Cardiovascular Medicine, Eberhard Karls-University Tübingen, Tübingen, Germany
- Section for Cardioimmunology, Eberhard Karls-University Tübingen, Tübingen, Germany
| |
Collapse
|
3
|
Abstract
Atherosclerosis is a silent chronic vascular pathology that is the cause of the majority of cardiovascular ischaemic events. The evolution of vascular disease involves a combination of endothelial dysfunction, extensive lipid deposition in the intima, exacerbated innate and adaptive immune responses, proliferation of vascular smooth muscle cells and remodelling of the extracellular matrix, resulting in the formation of an atherosclerotic plaque. High-risk plaques have a large acellular lipid-rich necrotic core with an overlying thin fibrous cap infiltrated by inflammatory cells and diffuse calcification. The formation of new fragile and leaky vessels that invade the expanding intima contributes to enlarge the necrotic core increasing the vulnerability of the plaque. In addition, biomechanical, haemodynamic and physical factors contribute to plaque destabilization. Upon erosion or rupture, these high-risk lipid-rich vulnerable plaques expose vascular structures or necrotic core components to the circulation, which causes the activation of tissue factor and the subsequent formation of a fibrin monolayer (coagulation cascade) and, concomitantly, the recruitment of circulating platelets and inflammatory cells. The interaction between exposed atherosclerotic plaque components, platelet receptors and coagulation factors eventually leads to platelet activation, aggregation and the subsequent formation of a superimposed thrombus (i.e. atherothrombosis) which may compromise the arterial lumen leading to the presentation of acute ischaemic syndromes. In this review, we will describe the progression of the atherosclerotic lesion along with the main morphological characteristics that predispose to plaque rupture, and discuss the multifaceted mechanisms that drive platelet activation and subsequent thrombus formation. Finally, we will consider the current scientific challenges and future research directions.
Collapse
Affiliation(s)
- L Badimon
- Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain; Cardiovascular Research Chair, UAB, Barcelona, Spain
| | | |
Collapse
|
4
|
Chen M, Glenn JV, Dasari S, McVicar C, Ward M, Colhoun L, Quinn M, Bierhaus A, Xu H, Stitt AW. RAGE regulates immune cell infiltration and angiogenesis in choroidal neovascularization. PLoS One 2014; 9:e89548. [PMID: 24586862 PMCID: PMC3935881 DOI: 10.1371/journal.pone.0089548] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2013] [Accepted: 01/23/2014] [Indexed: 12/17/2022] Open
Abstract
Purpose RAGE regulates pro-inflammatory responses in diverse cells and tissues. This study has investigated if RAGE plays a role in immune cell mobilization and choroidal neovascular pathology that is associated with the neovascular form of age-related macular degeneration (nvAMD). Methods RAGE null (RAGE−/−) mice and age-matched wild type (WT) control mice underwent laser photocoagulation to generate choroidal neovascularization (CNV) lesions which were then analyzed for morphology, S100B immunoreactivity and inflammatory cell infiltration. The chemotactic ability of bone marrow derived macrophages (BMDMs) towards S100B was investigated. Results RAGE expression was significantly increased in the retina during CNV of WT mice (p<0.001). RAGE−/− mice exhibited significantly reduced CNV lesion size when compared to WT controls (p<0.05). S100B mRNA was upregulated in the lasered WT retina but not RAGE−/− retina and S100B immunoreactivity was present within CNV lesions although levels were less when RAGE−/− mice were compared to WT controls. Activated microglia in lesions were considerably less abundant in RAGE−/− mice when compared to WT counterparts (p<0.001). A dose dependent chemotactic migration was observed in BMDMs from WT mice (p<0.05–0.01) but this was not apparent in cells isolated from RAGE−/− mice. Conclusions RAGE-S100B interactions appear to play an important role in CNV lesion formation by regulating pro-inflammatory and angiogenic responses. This study highlights the role of RAGE in inflammation-mediated outer retinal pathology.
Collapse
MESH Headings
- Animals
- Blotting, Western
- Cells, Cultured
- Chemotaxis
- Choroidal Neovascularization/immunology
- Choroidal Neovascularization/metabolism
- Choroidal Neovascularization/pathology
- Disease Models, Animal
- Macrophages/immunology
- Macrophages/metabolism
- Macrophages/pathology
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Neovascularization, Pathologic/immunology
- Neovascularization, Pathologic/metabolism
- Neovascularization, Pathologic/pathology
- RNA, Messenger/genetics
- Real-Time Polymerase Chain Reaction
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic/physiology
- Retina/immunology
- Retina/metabolism
- Retina/pathology
- Reverse Transcriptase Polymerase Chain Reaction
- S100 Calcium Binding Protein beta Subunit/genetics
- S100 Calcium Binding Protein beta Subunit/metabolism
Collapse
Affiliation(s)
- Mei Chen
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Josephine V. Glenn
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Shilpa Dasari
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Carmel McVicar
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Michael Ward
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Liza Colhoun
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Michael Quinn
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Angelika Bierhaus
- Department of Medicine and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany
| | - Heping Xu
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
| | - Alan W. Stitt
- Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, United Kingdom
- * E-mail:
| |
Collapse
|
5
|
Ren S, Fan X, Peng L, Pan L, Yu C, Tong J, Zhang W, Liu P. Expression of NF-κB, CD68 and CD105 in carotid atherosclerotic plaque. J Thorac Dis 2014; 5:771-6. [PMID: 24409354 DOI: 10.3978/j.issn.2072-1439.2013.12.36] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2013] [Accepted: 12/23/2013] [Indexed: 11/14/2022]
Abstract
Atherosclerotic plaque vulnerability is associated with cerebrovascular events in patients with carotid atherosclerosis. The aim of this study was to investigate the expression of inflammatory factors in carotid artherosclerotic plaques in order to explore its clinical significance in patients with carotid stenosis. Forty three patients with carotid stenosis were divided into symptomatic group (n=24) and asymptomatic group (n=19) based on clinical manifestation. All patients were treated with selective standard carotid endarterectomy (CEA); the carotid atherosclerotic plaques were removed surgically and studied pathologically to investigate the expression of nuclear factor-kappa κ (NF-κB), CD68 and CD105. The plaques were grouped into stable and unstable plaques based on thickness of the fibrous cap and the area of lipid-rich core in the plaques. The proportion of unstable plaques were significantly higher in symptomatic group than in asymptomatic group (70.8% vs. 63.2%, P=0.026). Results of immunohistochemisty staining showed that the expression of NF-κB, CD68 and CD105 in unstable plaques was higher than stable plaques (P<0.001). The association of the higher expression of these factors with instability of carotid plaque needs to be clarified in future study.
Collapse
Affiliation(s)
- Shiyan Ren
- Cardiovascular Center, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Xueqiang Fan
- Cardiovascular Center, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Liang Peng
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Lin Pan
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Changan Yu
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Jie Tong
- Department of Pathology, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Wenjian Zhang
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Peng Liu
- Cardiovascular Center, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| |
Collapse
|
6
|
Slevin M, Baldellou M, Hill E, Alexander Y, McDowell G, Murgatroyd C, Carroll M, Degens H, Krupinski J, Rovira N, Chowdhury M, Serracino-Inglott F, Badimon L. Novel methods for accurate identification, isolation, and genomic analysis of symptomatic microenvironments in atherosclerotic arteries. Methods Mol Biol 2014; 1135:289-305. [PMID: 24510873 DOI: 10.1007/978-1-4939-0320-7_24] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
A challenge facing surgeons is identification and selection of patients for carotid endarterectomy or coronary artery bypass/surgical intervention. While some patients with atherosclerosis develop unstable plaques liable to undergo thrombosis, others form more stable plaques and are asymptomatic. Identification of the cellular signaling mechanisms associated with production of the inflammatory, hemorrhagic lesions of mature heterogenic plaques will help significantly in our understanding of the differences in microenvironment associated with development of regions susceptible to rupture and thrombosis and may help to predict the risk of plaque rupture and guide surgical intervention to patients who will most benefit. Here, we demonstrate detailed and novel methodologies for successful and, more importantly, accurate and reproducible extraction, sampling, and analysis of micro-regions in stable and unstable coronary/carotid arteries. This information can be applied to samples from other origins and so should be useful for scientists working with micro-isolation techniques in all fields of biomedical science.
Collapse
Affiliation(s)
- Mark Slevin
- School of Healthcare Science, Manchester Metropolitan University, Manchester, UK
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Ren S, Fan X, Peng L, Pan L, Yu C, Tong J, Zhang W, Liu P. Expression of NF-κB, CD68 and CD105 in carotid atherosclerotic plaque. J Thorac Dis 2013. [PMID: 24409354 DOI: 10.3978/j.issn.2072-1439.2013.12.36.pmid:] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Atherosclerotic plaque vulnerability is associated with cerebrovascular events in patients with carotid atherosclerosis. The aim of this study was to investigate the expression of inflammatory factors in carotid artherosclerotic plaques in order to explore its clinical significance in patients with carotid stenosis. Forty three patients with carotid stenosis were divided into symptomatic group (n=24) and asymptomatic group (n=19) based on clinical manifestation. All patients were treated with selective standard carotid endarterectomy (CEA); the carotid atherosclerotic plaques were removed surgically and studied pathologically to investigate the expression of nuclear factor-kappa κ (NF-κB), CD68 and CD105. The plaques were grouped into stable and unstable plaques based on thickness of the fibrous cap and the area of lipid-rich core in the plaques. The proportion of unstable plaques were significantly higher in symptomatic group than in asymptomatic group (70.8% vs. 63.2%, P=0.026). Results of immunohistochemisty staining showed that the expression of NF-κB, CD68 and CD105 in unstable plaques was higher than stable plaques (P<0.001). The association of the higher expression of these factors with instability of carotid plaque needs to be clarified in future study.
Collapse
Affiliation(s)
- Shiyan Ren
- Cardiovascular Center, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Xueqiang Fan
- Cardiovascular Center, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Liang Peng
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Lin Pan
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Changan Yu
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Jie Tong
- Department of Pathology, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Wenjian Zhang
- Clinical research institute, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| | - Peng Liu
- Cardiovascular Center, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, China
| |
Collapse
|
8
|
Badimon L, Padró T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE 2013; 1:60-74. [PMID: 24062891 DOI: 10.1177/2048872612441582] [Citation(s) in RCA: 222] [Impact Index Per Article: 20.2] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 01/12/2012] [Accepted: 01/25/2012] [Indexed: 12/17/2022]
Abstract
Atherosclerosis is the underlying reason for nearly all causes of coronary artery disease and peripheral arterial disease and many cases of stroke. Atherosclerosis is a systemic inflammatory process characterised by the accumulation of lipids and macrophages/lymphocytes within the intima of large arteries. The deposition of these blood borne materials and the subsequent thickening of the wall often significantly compromise the residual lumen leading to ischaemic events distal to the arterial stenosis. However, these initial fatty streak lesions may also evolve into vulnerable plaques susceptible to rupture or erosion. Plaque disruption initiates both platelet adhesion and aggregation on the exposed vascular surface and the activation of the clotting cascade leading to the so-called atherothrombotic process. Yet, platelets have also been shown to be transporters of regulatory molecules (micro-RNA), to drive the inflammatory response and mediate atherosclerosis progression. Here we discuss our current understanding of the pathophysiological mechanisms involved in atherogenesis - from fatty streaks to complex and vulnerable atheromas - and highlight the molecular machinery used by platelets to regulate the atherogenic process, thrombosis and its clinical implications.
Collapse
Affiliation(s)
- Lina Badimon
- Cardiovascular Research Center, CSIC-ICCC, HSCSP, Barcelona, Spain ; CIBER OBN -Instituto Salud Carlos III, Madrid, Spain ; Cardiovascular Research Chair, UAB, Barcelona, Spain
| | | | | |
Collapse
|
9
|
Slevin M, Ahmed N, Wang Q, McDowell G, Badimon L. Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential? Vasc Cell 2012; 4:9. [PMID: 22546170 PMCID: PMC3508621 DOI: 10.1186/2045-824x-4-9] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2012] [Accepted: 04/30/2012] [Indexed: 01/07/2023] Open
Abstract
Natural health products (NHP) which include minerals, vitamins and herbal remedies are not generally considered by medical practitioners as conventional medicines and as such are not frequently prescribed by health centre's as either main-line or supplemental treatments. In the field of cardiovascular medicine, studies have shown that typically, less than half of patients suffering from coronary syndromes chose to take any form of NHP supplement and these products are rarely recommended by their medical practitioner. Vascular/endothelial cell damage is a key instigator of coronary arterial plaque development which often culminates in thrombosis and myocardial infarction (MI). Current treatment for patients known to be at risk of primary or secondary (MI) includes lipid lowering statins, anti-clotting agents (e.g. tissue plasminogen activator; tPA) and drugs for stabilization of blood pressure such as beta-blockers. However, evidence has been building which suggests that components of at least several NHP (e.g. aged garlic extract (AGExt), resveratrol and green tea extracts (GTE)) may have significant vascular protective effects through reduction of oxidative stress, lowering of blood pressure, reduction in platelet aggregation, vasodilation and inhibition of abnormal angiogenesis. Therefore, in this review we will discuss in detail the potential of these substances (chosen on the basis of their potency and complimentarity) as anti-atherosclerotic agents and the justification for their consideration as main-line additional supplements or prescriptions.
Collapse
Affiliation(s)
- Mark Slevin
- Centro de Investigación Cardiovascular CSIC-ICCC Hospital de la Santa Creu i Sant Pau, Pavelló del Convent Sant Antoni Maria Claret, 167 08025, Barcelona, Spain
- School of Healthcare Science, John Dalton Building, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK
| | - Nessar Ahmed
- School of Healthcare Science, John Dalton Building, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK
| | - Qiuyu Wang
- School of Healthcare Science, John Dalton Building, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK
| | - Garry McDowell
- Faculty of Health, Edge Hill University, Ormskirk, L39 4QP, UK
| | - Lina Badimon
- Centro de Investigación Cardiovascular CSIC-ICCC Hospital de la Santa Creu i Sant Pau, Pavelló del Convent Sant Antoni Maria Claret, 167 08025, Barcelona, Spain
| |
Collapse
|
10
|
Blaha M, Cermanova M, Blaha V, Jarolim P, Andrys C, Blazek M, Maly J, Smolej L, Zajic J, Masin V, Zimova R, Rehacek V. Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia. Atherosclerosis 2007; 224:4-11. [PMID: 17540382 DOI: 10.1016/j.atherosclerosis.2012.03.001] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2011] [Revised: 02/21/2012] [Accepted: 03/01/2012] [Indexed: 12/29/2022]
Abstract
Extracorporeal elimination is a method of LDL-lowering therapy that is used in severe familial hypercholesterolemia (FH) after other therapeutic approaches have failed. There are currently no universally accepted biomarkers that would allow determining necessary intensity of therapy and frequency of future therapeutic interventions. An ideal tool for immediate evaluation would be a readily measurable serum marker. We hypothesized that soluble endoglin (sCD105), a recently described indicator of endothelial dysfunction, may represent such a tool. Eleven patients with FH (three homozygous, eight heterozygous; Fredrickson type IIa, IIb) that have been monitored for 4.5+/-2.8 years were treated; eight by LDL-apheresis and three by hemorheopheresis. 40 sCD105 measurements were done, before and after two consecutive elimination procedures. Baseline serum sCD105 levels were significantly higher in the patients (5.74+/-1.47 microg/l in series I, 6.85+/-1.85 microg/l in series II) than in the control group (3.85+/-1.25 microg/l). They decreased to normal after LDL-elimination (p=0.0003) in all except for one patient. This return to normal was not due to a non-specific capture of endoglin in adsorption or filtration columns as demonstrated by measurement of sCD105 before and after passage through the elimination media. We conclude that the soluble endoglin levels in patients with severe FH remain elevated despite long-term intensive therapy and that they decrease after extracorporeal elimination. Endoglin can therefore serve as a marker for evaluation of the treatment efficacy and of the decreased atherosclerotic activity in patients with FH treated by extracorporeal LDL-cholesterol elimination.
Collapse
Affiliation(s)
- Milan Blaha
- 2nd Internal Clinic, Charles University School of Medicine and the Faculty Hospital, Hradec Kralove, Czech Republic.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|